Gemabank's (IMCB, MOEX: GEMA) rises its prices for biomaterial extraction and storage.
The cost of hematopoietic stem cell extraction for all tariffs will increase by 4,000 rubles.
The cost of cryogenic storage of biomaterial in the form of mesenchymal stem cells and tissue of the umbilical cord-placental complex will increase to 9 thousand rubles per year. The cost of long-term storage of mesenchymal stem cells and tissue of the umbilical cord-placental complex will also increase and the advance payment will be charged for 5-10-20 years.
Gemabank will also have new tariffs: Longevity — 100 years of storage, Complex storage — for all kinds of biomaterial for 12,000 rubles per year.
The prices will be changed gradually starting from May 12. The process will start in Moscow and its region, St. Petersburg and its region and the Southern Federal District, and later prices will rise in all regions of the Russian Federation.
IMCB (Gemabank) is a biotechnological company, part of Artgen Biotech group (MOEX: ABIO), dealing with personal storage of stem cells and development of gene therapy drugs against blood and immune system diseases.